Company news

Ironwood Pharmaceuticals, Inc. news in 2020

Ironwood Pharmaceuticals, Inc.'s news releases, calls and decks from 2020, newest first.

View company

Ironwood Pharmaceuticals Appoints Jay P. Shepard to Board of Directors

December 2, 2020

Ironwood Pharmaceuticals to Present at the 29th Annual Credit Suisse Healthcare Conference

November 5, 2020

Ironwood Pharmaceuticals Reports Strong Third Quarter 2020 Results and Increases Full Year 2020 Financial Guidance

November 4, 2020

Ironwood Pharmaceuticals Appoints Alexander Denner, Ph.D., to Board of Directors

November 4, 2020

Ironwood Pharmaceuticals to Host Third Quarter 2020 Investor Update Call

October 21, 2020

Ironwood to Discontinue IW-3718 Development Program Following Results from Planned Efficacy Assessment

September 28, 2020

Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million

August 5, 2020

Ironwood Pharmaceuticals to Host Second Quarter 2020 Investor Update Call

July 22, 2020

Ironwood Announces Updates Designed to Strengthen IW-3718 Phase III Program for Refractory Gastroesophageal Reflux Disease (GERD)

July 20, 2020

Ironwood and AbbVie Report Top-line Phase II Data for MD-7246 in Patients with Abdominal Pain Associated with Irritable Bowel Syndrome with Diarrhea (IBS-D)

May 26, 2020

Ironwood Pharmaceuticals Reports First Quarter 2020 Results and Provides Update on Impact of COVID-19 Pandemic

May 5, 2020

Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS® (linaclotide)

April 27, 2020

Ironwood Pharmaceuticals to Host First Quarter 2020 Investor Update Call

April 15, 2020

Ironwood Pharmaceuticals Provides Update on Impact of COVID-19

March 25, 2020

Ironwood Pharmaceuticals Announces Publication of Positive IW-3718 Phase IIb Data in Gastroenterology

February 25, 2020

Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences

February 24, 2020

Ironwood Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference

February 18, 2020

Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance

February 12, 2020

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call

January 29, 2020

Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation

January 21, 2020

Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation

January 5, 2020

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

January 1, 2020

Calls in 2020

Decks in 2020